Cargando…
Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies
BACKGROUND: Despite significant progress in drug treatment, the prognosis of patients with advanced pulmonary arterial hypertension (PAH) remains extremely poor. Many preclinical studies have reported the efficacy of stem cell (SC) therapy for PAH; however, this approach remains controversial. The a...
Autores principales: | Ding, Xian-Fei, Liang, Huo-Yan, Yuan, Bo, Li, Li-Feng, Wang, Tian, Kan, Quan-Cheng, Wang, Le-Xin, Sun, Tong-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374914/ https://www.ncbi.nlm.nih.gov/pubmed/30760312 http://dx.doi.org/10.1186/s13287-019-1162-8 |
Ejemplares similares
-
Efficacy of mesenchymal stem cell therapy for sepsis: a meta-analysis of preclinical studies
por: Sun, Xue-Yi, et al.
Publicado: (2020) -
Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021) -
New progress in diagnosis and treatment of pulmonary arterial hypertension
por: Zhang, Zai-qiang, et al.
Publicado: (2022) -
Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2021) -
Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)